Itaconate’s role as an immune metabolic component in the crosstalk between tumor-associated macrophages and the tumor microenvironment indicates that dysregulated IRG1 expression may promote tumorigenesis by modulating antitumor immunity [29, 123]. The gene discussed is ACOD1; the disease is neoplasm.